Back
Incyte 10K Form
Buy
55
INCY
Incyte
Last Price:
$71.11
Seasonality Move:
0.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-30 | 10Q | INCY/Incyte Quarterly |
2023-10-31 | 10Q | INCY/Incyte Quarterly |
2023-08-01 | 10Q | INCY/Incyte Quarterly |
2023-05-02 | 10Q | INCY/Incyte Quarterly |
2022-11-01 | 10Q | INCY/Incyte Quarterly |
2022-08-02 | 10Q | INCY/Incyte Quarterly |
Receive INCY News And Ratings
See the #1 stock for the next 7 days that we like better than INCY
INCY Financial Statistics
Sales & Book Value
Annual Sales: | $4.2B |
---|---|
Cash Flow: | $363.8M |
Price / Cash Flow: | 63.82 |
Annual Sales: | $17.82 |
Price / Book: | 3.97 |
Profitability
EPS (TTM): | 0.27000 |
---|---|
Net Income (TTM): | $32.6M |
Gross Margin: | $3.9B |
Return on Equity: | 0.81% |
Return on Assets: | 0.56% |
Incyte Earnings Forecast
Key Incyte Financial Ratios
-
The Gross Profit Margin over the past 32 years for INCY is 92.64%.
-
The Selling, General & Administrative Expenses for INCY have been equal to 28.81% of Gross Profit Margin.
-
The Research & Development expenses have been 61.46% of Revenue.
-
The Interest Expense is 6.99% of Operating Income.
-
The Net Earning history of INCY is 0.77% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 18 years.
Incyte Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | INCY |
CUSIP: | 45337C |
Website: | incyte.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.97 |
Quick Ratio: | 1.83 |
Price-to-Earnings
Trailing P/E Ratio: | 471.93 |
---|---|
Forward P/E Ratio: | 10.56 |